Blood filtering therapy aimed at soothing immunotherapy side effects
NCT ID NCT06646016
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 19 times
Summary
This study tested a treatment called extracorporeal photopheresis (ECP) for people with melanoma or lung cancer who developed severe colitis (gut inflammation) from immunotherapy and didn't get better with steroids. ECP involves taking blood, treating white blood cells with a light-activated drug and UV light, then returning them to the body. The goal was to see if ECP could calm the colitis better than standard care. However, the study was withdrawn before enrolling any participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE-RELATED COLITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
Conditions
Explore the condition pages connected to this study.